DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
1-Year Return
0.48%
This Quarter Return
+10.93%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$355M
AUM Growth
-$16.8M
(-4.5%)
Cap. Flow
-$23.9M
Cap. Flow
% of AUM
-6.74%
Top 10 Holdings %
Top 10 Hldgs %
50.26%
Holding
91
New
4
Increased
16
Reduced
25
Closed
11
Top Buys
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$8.48M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$4.38M |
| 3 |
Biohaven
BHVN
|
$3.28M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$2.88M |
| 5 |
KalVista Pharmaceuticals
KALV
|
$2.44M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$16.6M |
| 2 |
CBAY
Cymabay Therapeutics
CBAY
|
$9.61M |
| 3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$4.65M |
| 4 |
89bio
ETNB
|
$4.21M |
| 5 |
Adicet Bio
ACET
|
$2.72M |
Sector Composition
| 1 | Healthcare | 81.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
KalVista Pharmaceuticals
KALV
$765M
| $4.16M | 1.17% |
616,032
+360,719
| +141% | +$2.44M |
|
|
27
89bio
ETNB
$1.28B
| $4.13M | 1.16% |
324,173
-330,689
| -50% | -$4.21M |
|
|
CSII
28
DELISTED
Cardiovascular Systems, Inc.
CSII
| $3.91M | 1.1% |
286,988
| – | – |
|
|
DICE
29
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $3.85M | 1.09% |
123,500
+45,000
| +57% | +$1.4M |
|
|
FSTX
30
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $3.65M | 1.03% |
576,881
| – | – |
|
|
BCYC
31
Bicycle Therapeutics
BCYC
$483M
| $3.62M | 1.02% |
122,200
| – | – |
|
|
MRTX
32
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.33M | 0.94% |
73,600
+2,000
| +3% | +$90.6K |
|
33
Axogen
AXGN
$709M
| $3.31M | 0.93% |
332,103
| – | – |
|
34
AtriCure
ATRC
$1.77B
| $3.2M | 0.9% |
72,029
| – | – |
|
35
Compass Therapeutics
CMPX
$578M
| $3.03M | 0.85% |
602,051
+413,957
| +220% | +$2.08M |
|
36
Arcus Biosciences
RCUS
$1.23B
| $2.94M | 0.83% |
142,217
-36,500
| -20% | -$755K |
|
|
37
BioCryst Pharmaceuticals
BCRX
$1.74B
| $2.88M | 0.81% |
+251,000
| New | +$2.88M |
|
38
MediWound
MDWD
$182M
| $2.75M | 0.78% |
204,082
| – | – |
|
39
Accuray
ARAY
$170M
| $2.55M | 0.72% |
1,222,358
+280,558
| +30% | +$586K |
|
40
Century Therapeutics
IPSC
$41.4M
| $2.44M | 0.69% |
475,367
| – | – |
|
41
Mersana Therapeutics
MRSN
$35.5M
| $2.42M | 0.68% |
16,539
+1,428
| +9% | +$209K |
|
42
Galapagos
GLPG
$2.1B
| $2.34M | 0.66% |
52,675
+10,000
| +23% | +$444K |
|
|
AUTL
43
Autolus Therapeutics
AUTL
$386M
| $2.23M | 0.63% |
1,176,150
+680,000
| +137% | +$1.29M |
|
44
Neuronetics
STIM
$219M
| $2.16M | 0.61% |
313,717
| – | – |
|
|
VIGL
45
DELISTED
Vigil Neuroscience
VIGL
| $2.11M | 0.59% |
168,846
-47,549
| -22% | -$594K |
|
46
Larimar Therapeutics
LRMR
$331M
| $1.95M | 0.55% |
473,136
-101,860
| -18% | -$421K |
|
|
ITOS
47
DELISTED
iTeos Therapeutics
ITOS
| $1.92M | 0.54% |
98,560
+1,000
| +1% | +$19.5K |
|
48
Kura Oncology
KURA
$706M
| $1.8M | 0.51% |
144,784
-61,545
| -30% | -$764K |
|
49
Keros Therapeutics
KROS
$632M
| $1.58M | 0.45% |
33,000
-6,000
| -15% | -$288K |
|
50
Oric Pharmaceuticals
ORIC
$1.05B
| $1.56M | 0.44% |
264,237
-149,289
| -36% | -$879K |
|